| Literature DB >> 30992324 |
Dan Li1, Lisa M Harlan-Williams1,2, Easwari Kumaraswamy1,3, Roy A Jensen4,2,3,5,6.
Abstract
BRCA1 (breast cancer 1, early onset), a well-known breast cancer susceptibility gene, is a highly alternatively spliced gene. BRCA1 alternative splicing may serve as an alternative regulatory mechanism for the inactivation of the BRCA1 gene in both hereditary and sporadic breast cancers, and other BRCA1-associated cancers. The alternative transcripts of BRCA1 can mimic known functions, possess unique functions compared with the full-length BRCA1 transcript, and in some cases, appear to function in opposition to full-length BRCA1 In this review, we will summarize the functional "naturally occurring" alternative splicing transcripts of BRCA1 and then discuss the latest next-generation sequencing-based detection methods and techniques to detect alternative BRCA1 splicing patterns and their potential use in cancer diagnosis, prognosis, and therapy. ©2019 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30992324 PMCID: PMC6497576 DOI: 10.1158/0008-5472.CAN-18-3190
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701